Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: Implications for pharmacological intervention

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 5, 1999, Pages 407-411

  Marcus, Stacy J ^a   Ware, Russell E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

F cells; Fetal hemoglobin; Hydroxyurea; Infants; Sickle cell disease

Indexed keywords

HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA;

ARTICLE; CHILDHOOD DISEASE; DISEASE SEVERITY; FEMALE; HEMOGLOBIN SYNTHESIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

AGING; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; COHORT STUDIES; FEMALE; FETAL HEMOGLOBIN; HEMOGLOBIN C; HEMOGLOBIN, SICKLE; HOMOZYGOTE; HUMANS; HYDROXYUREA; INFANT; MALE;

EID: 0033505007     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199909000-00013     Document Type: Article

References (38)

1. Brugnara C. Reference values in infancy and childhood. In: Nathan DG Orkins SH, eds. Hematology of infancy and childhood. Philadelphia: Saunders, 1997:appendix 22;xii.
2. Mason K, Grandison Y, Hayes RJ, et al. Post-natal decline of fetal haemoglobin in homozygous sickle cell disease: relationship to parental Hb F levels. Br J Haematol 1982:52:455-63.
3. Stevens MCG, Maude GH, Beckford M, et al. Haematological change in sickle cell-haemoglobin C disease and in sickle cell-beta thalassaemia: a cohort study from birth. Br J Haematol 1985;60: 279-92.
4. Brown AK, Sleeper LA, Miller ST, et al. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease. Arch Pediatr Adolesc Med 1994;148:796-804.
5. Stevens MCG, Hayes RJ, Vaidya S, et al. Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood. J Pediatr 1981;98:37-41.
6. Bailey K, Morris JS, Thomas P, et al. Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child 1992;67:517-20.
7. Pearson HA, Gallagher D, Chilcote R, et al. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics 1985;76: 392-7.
8. Koshy M, Entsuah R, Koranda A, et al. Leg ulcers in patients with sickle cell disease. Blood 1989;74:1403-8.
9. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. N Engl J Med 1991;325:11-6.
10. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84:643-9.
11. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. N Engl J Med 1994;330:1639-44.
12. Shepard MK, Weatherall DJ, Conley CL. Semi-quantitative estimation of the distribution of fetal hemoglobin in red cell populations. Bull J Hopkins Hospital 1962;110:293-310.
13. Boyer SH, Belding TK, Margolet L, et al. Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. Science 1975;188:361-3.
14. Dover GJ, Boyer SH, Charache S. et al. Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med 1978;299:1428-35.
15. Wood WG, Stamatoyannopoulos G, Lim G, et al. F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. Blood 1975;46:671-82.
16. Marcus SJ, Kinney TR, Schultz WH, et al. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease. Am J Hematol 1997;54:40-46.
17. Kinney TR, Sawtschenko M, Whorton M, et al. Techniques comparison and report of the North Carolina experience. Pediatrics 1989;83(suppl):843-8.
18. Bunn HF. Human hemoglobins: normal and abnormal. In: Nathan DG, Orkins SH. eds. Hematology of infancy and childhood. Philadelphia: Saunders, 1997:729-61.
19. Wood WG. Increased HbF in adult life. Baillieres Clin Haematol 1993;6:177-213.
20. Odenheimer DJ, Sarnaik SA, Whitten CF, et al. The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia. Am J Med Genet 1987;27:525-35.
21. Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989;84:500-8.
22. Powars DR, Weiss JN, Chan LS, et al. Is there a threshold of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 1984;63:921-6.
23. Baum KF, Dunn DT, Maude GH, et al. The painful crisis of homozygous sickle cell disease: a study of risk factors. Arch Intern Med 1987;147:1231-4.
24. Powars DR, Schroeder WA, Weiss JN, et al. Lack of influence of fetal hemoglobin levels or erthyrocyte indices on the severity of sickle cell anemia. J Clin Invest 1980;65:732-40.
25. Singer K, Singer L. The gelling phenomenon of sickle cell hemoglobin: its biologic and diagnostic significance. Blood 1953;8: 1008-23.
26. Bertles JF, Rabinowitz R, Dobler J. Hemoglobin interaction: modification of solid phase composition in the sickling phenomenon. Science 1970;169:375-7.
27. Bookchin RM, Nagel RL, Balazs T. Role of hybrid tetramer formation in gelation of haemoglobin S. Nature 1975;256:667-8.
28. Benesch RE, Edalji R, Benesch R, et al. Solubilization of hemoglobin S by other hemoglobins. Proc Natl Acad Sci USA 1988; 77:5130-4.
29. Sunshine HR, Hofrichter J, Eaton WA. Gelation of sickle cell hemoglobin in mixtures with normal adult and fetal hemoglobins. J Mol Biol 1979;133:435-67.
30. 2 on the polymerization of hemoglobin S at physiologic ligand saturations. Proc Natl Acad Sci USA 1993;90:5039-43.
31. Maier-Redelsperger M, Noguchi CT, de Montalembert M, et al. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian prospective study on sickle cell disease. Blood 1994; 84:3182-8.
32. Charache S, Dover GJ, Moore RD, et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992;79:2555-65.
33. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-22.
34. Jayabose S, Tugal O, Sandoval C, et al. Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. J Pediatr 1996;129:559-65.
35. Scott JP, Hillery CA, Brown ER, et al. Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 1996; 128:820-8.
36. Ferster A, Vermylen C. Cornu G, et al. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 1996; 88:1960-4.
37. de Montalembert M, Belloy M, Bernaudin F, et al. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. J Pediatr Hematol Oncol 1997;19:313-8.
38. HUG-KIDS Study Group. Phase I/II multicenter pediatric trial of hydroxyurea (HUG-KIDS) [abtract]. Blood 1997;90:445a.